Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) was the recipient of a large decrease in short interest in February. As of February 28th, there was short interest totalling 1,440,000 shares, a decrease of 23.0% from the February 13th total of 1,870,000 shares. Based on an average daily trading volume, of 346,500 shares, the short-interest ratio is presently 4.2 days. Currently, 3.9% of the company’s shares are sold short.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on ASTH shares. Macquarie upgraded shares of Astrana Health to a “hold” rating in a research note on Monday, December 16th. Bank of America decreased their price target on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a research note on Tuesday, March 4th. Robert W. Baird cut their price objective on shares of Astrana Health from $86.00 to $50.00 and set an “outperform” rating on the stock in a research report on Monday, March 3rd. Truist Financial decreased their price target on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a research note on Monday, January 13th. Finally, Stifel Nicolaus dropped their target price on Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Astrana Health presently has an average rating of “Moderate Buy” and an average target price of $56.83.
Check Out Our Latest Stock Report on ASTH
Astrana Health Stock Performance
Astrana Health (NASDAQ:ASTH – Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). The business had revenue of $665.21 million during the quarter, compared to the consensus estimate of $617.24 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. As a group, sell-side analysts expect that Astrana Health will post 1.15 earnings per share for the current year.
Institutional Trading of Astrana Health
Large investors have recently added to or reduced their stakes in the stock. Janus Henderson Group PLC bought a new position in shares of Astrana Health during the 3rd quarter valued at approximately $1,164,000. Royce & Associates LP purchased a new position in Astrana Health in the third quarter valued at approximately $6,661,000. Principal Financial Group Inc. bought a new position in Astrana Health during the third quarter valued at $13,383,000. Loomis Sayles & Co. L P purchased a new stake in Astrana Health in the third quarter worth $30,251,000. Finally, Victory Capital Management Inc. purchased a new stake in Astrana Health in the third quarter worth $2,596,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.
Astrana Health Company Profile
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Further Reading
- Five stocks we like better than Astrana Health
- Profitably Trade Stocks at 52-Week Highs
- How to Build the Ultimate Everything ETF Portfolio
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.